| 维思通与氯氮平治疗难治性精神分裂症的临床对照研究 |
| |
| 引用本文： | 刘英. 维思通与氯氮平治疗难治性精神分裂症的临床对照研究[J]. 菏泽医学专科学校学报, 2005, 17(1): 13-14 |
| |
| 作者姓名： | 刘英 |
| |
| 作者单位： | 菏泽市第三人民医院,山东,菏泽,274000 |
| |
| 摘 要： | 目的探讨维思通与氯氮平治疗难治性精神分裂症的疗效和不良反应。方法应用维思通和氯氮平治疗难冶性精神分裂症各35例,疗程12周,在用药前及治疗后1、2、4、8、12周应用PANSS、TESS评定疗效和不良反应。结果维思通与氯氮平疗效相当,两组不良反应比较,P<0.05。结论维思通治疗难治性精神分裂症疗效较好,安全性较大。
|
| 关 键 词： | 维思通／治疗应用 氯氮平／治疗应用 难治性分裂症／治疗 |
| 文章编号： | 1008-4118(2005)01-0013-02 |
| 修稿时间： | 2004-12-12 |
A Comparative Study of Risporidone and Clozapine in the Treatment of Refractory Schizophrenia |
| |
| LIU Ying. A Comparative Study of Risporidone and Clozapine in the Treatment of Refractory Schizophrenia[J]. Journal of Heze Medical College, 2005, 17(1): 13-14 |
| |
| Authors: | LIU Ying |
| |
| Abstract: | Objective To compare the curative effects and side effects on riperidone and clozapine in the treatment of refactony schizophrenia. Methods 35 patients with refractory schizophrenia were randomly assigned into riperidone group and clozapine group. The course of treatment is 12 weeks, and measured with PANSS and TESS before treatment and1?2?4?8?12 weeks after the treatment.Results Both of the drugs were similar in curative effects. Riperidone showed fewer side effects than clozapine. Conclusion Riperidone is effective and safe in the treatment of refractory schizophrenia. |
| |
| Keywords: | Riperidone/therapeutic use Clozapine/therapeutic use Refractory schizophrenia/therapy |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
